Search Results for: medical treatment

bicol tuberculosis TB

DOH-Bicol Achieves Remarkable 92% TB Treatment Success Rate

The Department of Health-Center for Health Development in Bicol (DOH CHD-5) announced a 92% treatment success rate for tuberculosis (TB) cases for Q1 2024. This achievement was highlighted during the “Kapihan sa Bagong Pilipinas” briefing held at the Bicol Medical Center in Naga City. This success is indicative of the region’s robust health initiatives and effective implementation of TB treatment protocols. 

Read More »
Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

Press Release – Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.

Read More »

Have a health question?

Share it with us and get it answered by a doctor!